Cargando…

Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design

BACKGROUND: Research is urgently needed to reduce the morbidity and mortality of Lassa fever (LF), including clinical trials to test new therapies and to verify the efficacy and safety of the only current treatment recommendation, ribavirin, which has a weak clinical evidence base. To help establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merson, Laura, Bourner, Josephine, Jalloh, Sulaiman, Erber, Astrid, Salam, Alex Paddy, Flahault, Antoine, Olliaro, Piero L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486098/ https://www.ncbi.nlm.nih.gov/pubmed/34547033 http://dx.doi.org/10.1371/journal.pntd.0009788

Ejemplares similares

Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021)

A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
por: Olayinka, Adebola Tolulope, et al.
Publicado: (2022)

A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings
por: Bourner, Josephine, et al.
Publicado: (2023)

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
por: Salam, Alex P., et al.
Publicado: (2022)

The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): A case study of bubonic plague
por: Rasoanaivo, Tsinjo Fehizoro, et al.
Publicado: (2021)

A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks—results from the Lassa fever pilot
por: Sigfrid, Louise, et al.
Publicado: (2019)

Historical Lassa Fever Reports and 30-year Clinical Update
por: Macher, Abe M., et al.
Publicado: (2006)

965. Applying Clinical Prediction Tools to Patients with Lassa Fever
por: Chiosi, John, et al.
Publicado: (2018)

Using a consensus technique for improving the methodology of clinical trials assessing treatments for Cutaneous Leishmaniasis
por: Erber, Astrid, et al.
Publicado: (2015)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management
por: Sundar, Shyam, et al.
Publicado: (2007)

Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018
por: Ashcroft, Jonathan W., et al.
Publicado: (2022)

Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria
por: Olayinka, Adebola T., et al.
Publicado: (2022)

On the Front Lines of Lassa Fever
por: Bausch, Daniel G., et al.
Publicado: (2004)

Animal Models of Lassa Fever
por: Sattler, Rachel A., et al.
Publicado: (2020)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

Lassa Fever 2016 Outbreak in Plateau State, Nigeria—The Changing Epidemiology and Clinical Presentation
por: Shehu, Nathan Y., et al.
Publicado: (2018)

Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study
por: Duvignaud, Alexandre, et al.
Publicado: (2021)

Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries
por: Kayem, Nzelle Delphine, et al.
Publicado: (2019)

Report of a fatal case of Lassa fever in Parakou in 2018: clinical, therapeutic and diagnostic aspects
por: Attinsounon, Cossi Angelo, et al.
Publicado: (2018)

Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
por: Ilori, Elsie A., et al.
Publicado: (2019)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

Laboratory Diagnosis of Lassa Fever, Liberia
por: Panning, Marcus, et al.
Publicado: (2010)

Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012)

Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)

Lassa fever and global health security
por: The Lancet Infectious Diseases
Publicado: (2018)

PROSPECTS OF LASSA FEVER CANDIDATE VACCINES
por: Isaac, Ademusire Babatunde, et al.
Publicado: (2022)

Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria
por: Ugwu, Chinedu, et al.
Publicado: (2022)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

Lassa Fever in Post-Conflict Sierra Leone
por: Shaffer, Jeffrey G., et al.
Publicado: (2014)

Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
por: Cheng, Hung-Yuan, et al.
Publicado: (2022)

Tecovirimat for Monkeypox in the Central African Republic under Expanded Access
por: Mbrenga, Festus, et al.
Publicado: (2022)

Risk Maps of Lassa Fever in West Africa
por: Fichet-Calvet, Elisabeth, et al.
Publicado: (2009)

Mastomys natalensis and Lassa Fever, West Africa
por: Lecompte, Emilie, et al.
Publicado: (2006)

Imported Lassa Fever, Pennsylvania, USA, 2010
por: Amorosa, Valerianna, et al.
Publicado: (2010)

Mapping the zoonotic niche of Lassa fever in Africa
por: Mylne, Adrian Q. N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pbald9ulf4jr5h63k727h4fbbu